Embark Holdings ApS — Credit Rating and Financial Key Figures

CVR number: 44152223
Ottiliavej 9, 2500 Valby
cth@embarkbiotech.com
tel: 45484449

Income statement (kDKK)

2023
2024
Fiscal period length1212
Net sales
Gross profit17 912.2916 029.55
Employee benefit expenses-9 549.54-3 638.73
EBIT8 362.7612 390.82
Other financial income191.031 199.92
Other financial expenses- 211.93-9.04
Reduction non-current investment assets-17 255.62
Net income from associates (fin.)45 688.76
Pre-tax profit54 030.62-3 673.91
Income taxes138.84
Net earnings54 030.62-3 535.07

Assets (kDKK)

2023
2024
Intangible assets total
Tangible assets total
Holdings in group member companies2 606.102 606.10
Investments total2 606.102 606.10
Long term receivables total
Inventories total
Current amounts owed by group member comp.2 512.591 609.81
Current other receivables1 152.93
Current deferred tax assets138.84
Short term receivables total3 665.521 748.65
Cash and bank deposits107 441.9528 437.15
Cash and cash equivalents107 441.9528 437.15
Balance sheet total (assets)113 713.5832 791.90

Equity and liabilities (kDKK)

2023
2024
Share capital320.00320.00
Shares repurchased61 874.72
Retained earnings-22 169.7231 860.89
Profit of the financial year54 030.62-3 535.07
Shareholders equity total94 055.6228 645.83
Non-current liabilities total
Current trade creditors3 562.76131.74
Other non-interest bearing current liabilities12 480.264 014.33
Accruals and deferred income3 614.94
Current liabilities total19 657.964 146.07
Balance sheet total (liabilities)113 713.5832 791.90
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.